-
Volg het forum via Google Nieuws
Nieuws Studie toont tekenen van toxiciteit in GM maïs goedgekeurd voor menselijke consumptie
Bezoekers in dit topic
- Lid geworden
- 21 okt 2007
- Berichten
- 12.103
- Waardering
- 390
- Lengte
- 1m66
- Massa
- 66kg
- Vetpercentage
- 6%
ik heb geen scheikunde gedaan maar volgens mij veranderen ze de ?cel? structuur een beetje waardoor het opeens heel moeilijk wordt om te verwerken voor een nier of lever wat op langere termijn dan schade kan aanrichten. Dit is dus niet hetzelfde als pesticiden in groenten/fruit of kwik in vis
- Lid geworden
- 8 jun 2006
- Berichten
- 9.246
- Waardering
- 33
- Lengte
- 1m90
- Massa
- 103kg
- Vetpercentage
- 12%
en niet biologisch? op biologisch eten kan de wereld nou eenmaal niet overleven.biologische niks.
1: Arch Environ Contam Toxicol. 2007 May;52(4):596-602. Epub 2007 Mar 13.
New analysis of a rat feeding study with a genetically modified maize reveals signs of hepatorenal toxicity.
Séralini GE, Cellier D, de Vendomois JS.
Committee for Independent Information and Research on Genetic Engineering CRIIGEN, Paris, France. criigen@unicaen.fr
Health risk assessment of genetically modified organisms (GMOs) cultivated for food or feed is under debate throughout the world, and very little data have been published on mid- or long-term toxicological studies with mammals. One of these studies performed under the responsibility of Monsanto Company with a transgenic corn MON863 has been subjected to questions from regulatory reviewers in Europe, where it was finally approved in 2005. This necessitated a new assessment of kidney pathological findings, and the results remained controversial. An Appeal Court action in Germany (Münster) allowed public access in June 2005 to all the crude data from this 90-day rat-feeding study. We independently re-analyzed these data. Appropriate statistics were added, such as a multivariate analysis of the growth curves, and for biochemical parameters comparisons between GMO-treated rats and the controls fed with an equivalent normal diet, and separately with six reference diets with different compositions. We observed that after the consumption of MON863, rats showed slight but dose-related significant variations in growth for both coïtuses, resulting in 3.3% decrease in weight for males and 3.7% increase for females. Chemistry measurements reveal signs of hepatorenal toxicity, marked also by differential sensitivities in males and females. Triglycerides increased by 24-40% in females (either at week 14, dose 11% or at week 5, dose 33%, respectively); urine phosphorus and sodium excretions diminished in males by 31-35% (week 14, dose 33%) for the most important results significantly linked to the treatment in comparison to seven diets tested. Longer experiments are essential in order to indicate the real nature and extent of the possible pathology; with the present data it cannot be concluded that GM corn MON863 is a safe product.
PMID: 17356802 [PubMed - indexed for MEDLINE]
New analysis of a rat feeding study with a genetically modified maize reveals signs of hepatorenal toxicity.
Séralini GE, Cellier D, de Vendomois JS.
Committee for Independent Information and Research on Genetic Engineering CRIIGEN, Paris, France. criigen@unicaen.fr
Health risk assessment of genetically modified organisms (GMOs) cultivated for food or feed is under debate throughout the world, and very little data have been published on mid- or long-term toxicological studies with mammals. One of these studies performed under the responsibility of Monsanto Company with a transgenic corn MON863 has been subjected to questions from regulatory reviewers in Europe, where it was finally approved in 2005. This necessitated a new assessment of kidney pathological findings, and the results remained controversial. An Appeal Court action in Germany (Münster) allowed public access in June 2005 to all the crude data from this 90-day rat-feeding study. We independently re-analyzed these data. Appropriate statistics were added, such as a multivariate analysis of the growth curves, and for biochemical parameters comparisons between GMO-treated rats and the controls fed with an equivalent normal diet, and separately with six reference diets with different compositions. We observed that after the consumption of MON863, rats showed slight but dose-related significant variations in growth for both coïtuses, resulting in 3.3% decrease in weight for males and 3.7% increase for females. Chemistry measurements reveal signs of hepatorenal toxicity, marked also by differential sensitivities in males and females. Triglycerides increased by 24-40% in females (either at week 14, dose 11% or at week 5, dose 33%, respectively); urine phosphorus and sodium excretions diminished in males by 31-35% (week 14, dose 33%) for the most important results significantly linked to the treatment in comparison to seven diets tested. Longer experiments are essential in order to indicate the real nature and extent of the possible pathology; with the present data it cannot be concluded that GM corn MON863 is a safe product.
PMID: 17356802 [PubMed - indexed for MEDLINE]
- Lid geworden
- 13 jun 2005
- Berichten
- 36.950
- Waardering
- 279
niet best dan eigenlijk. Maar denk dat dit met veel meer produkten het geval is waarvan wij geen weet hebben. Kwalijke zaak.
- Lid geworden
- 10 apr 2008
- Berichten
- 6.165
- Waardering
- 252
- Lengte
- 1m86
- Massa
- 95kg
- Vetpercentage
- 12%
Overal is wel iets mis mee jammer genoeg.
Verder blijkt verder onderzoek noodzakelijk zoals builderB aanhaalt, waarschijnlijk weer een storm in een glas water.
Verder is de maïs die op normale manier gekweekt wordt, waarschijnlijk niet veel beter.
Verder blijkt verder onderzoek noodzakelijk zoals builderB aanhaalt, waarschijnlijk weer een storm in een glas water.
Verder is de maïs die op normale manier gekweekt wordt, waarschijnlijk niet veel beter.
